+++
title = "Figure S9-12"
date = "2019-01-24"
author = "Lukasz Migas"
cover = ""
description = "Figure S9-12 - Collision energy activated IM-MS heat maps of IgG1 NIST and Herceptin® lot A/B/C"
+++

## Figure caption

Collision energy activated IM-MS heat map of the IgG1 NIST/Herceptin® lot A/B/C mAb with (a) glycans, (b) truncated (endoS2 treated) glycans and (c) no glycans. Mass selected 24+ charge state with collision voltage range 4-200 V, n=3.

Figure S8: IgG1 NIST mAb
Figure S9: Herceptin® mAb lot A
Figure S10: Herceptin® mAb lot B
Figure S11: Herceptin® mAb lot C

[Open in another tab](https://upton-herceptin-2019.netlify.app/assets/Figure_S9-12.html)

## Interactive figure

<iframe
    width="700"
    frameborder="0"
    height="800"
    src="https://upton-herceptin-2019.netlify.app/assets/Figure_S9-12.html"
    style="background: #FFFFFF;"
></iframe>

## Reference

[Upton R, Migas LG, Pacholarz KJ, Beniston RG, Estdale S, Firth D, Barran PE.Hybrid mass spectrometry methods reveal lot-to-lot differences and delineate the effects of glycosylation on the tertiary structure of Herceptin®. Chem. Sci. Advance Article (2019).](https://pubs.rsc.org/en/content/articlepdf/2019/sc/c8sc05029e)